Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Yonekawa

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Acta Neuropathologica|May 1, 2004
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomasYoshikazu Okamoto, Pier-Luigi Di Patre, Christoph Burkhard, et al.
Oncology|June 13, 2012
Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trialChristoph Oehler, Karl Frei, Elisabeth J Rushing, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 4, 2012
ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injuryMasayuki Fujioka, Takafumi Nakano, Kazuhide Hayakawa, et al.
Cancer Research|October 7, 2004
Genetic pathways to glioblastoma: a population-based studyHiroko Ohgaki, Pierre Dessen, Benjamin Jourde, et al.
Molecular Cancer Therapeutics|April 8, 2011
Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trialMonika E Hegi, Annie-Claire Diserens, Pierre Bady, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Acta Neuropathologica|May 1, 2004
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomasYoshikazu Okamoto, Pier-Luigi Di Patre, Christoph Burkhard, et al.
Oncology|June 13, 2012
Patupilone (epothilone B) for recurrent glioblastoma: clinical outcome and translational analysis of a single-institution phase I/II trialChristoph Oehler, Karl Frei, Elisabeth J Rushing, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 4, 2012
ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injuryMasayuki Fujioka, Takafumi Nakano, Kazuhide Hayakawa, et al.
Cancer Research|October 7, 2004
Genetic pathways to glioblastoma: a population-based studyHiroko Ohgaki, Pierre Dessen, Benjamin Jourde, et al.
Molecular Cancer Therapeutics|April 8, 2011
Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trialMonika E Hegi, Annie-Claire Diserens, Pierre Bady, et al.
Pageof 7